Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BVXV BiondVax制药 > Detailed Quotes

BVXV BiondVax制药

0.730
+0.070+10.61%
Close 09/30 16:00 ET
0.7300.0000.00%
Post Mkt Price 09/30 16:12 ET
High
0.730
Open
0.650
Turnover
158.65K
Low
0.650
Pre Close
0.660
Volume
227.70K
Market Cap
13.64M
P/E(TTM)
Loss
52wk High
3.490
Shares
18.68M
P/E(Static)
Loss
52wk Low
0.646
Float Cap
10.51M
Bid/Ask %
0.00%
Historical High
62.000
Shs Float
14.39M
Volume Ratio
1.35
Historical Low
0.646
Dividend TTM
--
Div Yield TTM
--
P/B
10.74
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.58%
Amplitude
12.11%
Avg Price
0.696
Lot Size
1
Float Cap
10.51M
Bid/Ask %
0.00%
Historical High
62.000
Shs Float
14.39M
Volume Ratio
1.35
Historical Low
0.646
Dividend TTM
--
P/B
10.74
Dividend LFY
--
Turnover Ratio
1.58%
Amplitude
12.11%
Avg Price
0.696
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
CEO: Mr. Amir Reichman
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...